These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 11329055)
1. Breast cancer genetics: what we know and what we need. Nathanson KL; Wooster R; Weber BL Nat Med; 2001 May; 7(5):552-6. PubMed ID: 11329055 [TBL] [Abstract][Full Text] [Related]
2. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399 [TBL] [Abstract][Full Text] [Related]
3. Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population. Pääkkönen K; Sauramo S; Sarantaus L; Vahteristo P; Hartikainen A; Vehmanen P; Ignatius J; Ollikainen V; Kääriäinen H; Vauramo E; Nevanlinna H; Krahe R; Holli K; Kere J Genet Epidemiol; 2001 Feb; 20(2):239-46. PubMed ID: 11180449 [TBL] [Abstract][Full Text] [Related]
4. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition]. Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051 [TBL] [Abstract][Full Text] [Related]
5. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836 [TBL] [Abstract][Full Text] [Related]
6. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Rebbeck TR; Wang Y; Kantoff PW; Krithivas K; Neuhausen SL; Godwin AK; Daly MB; Narod SA; Brunet JS; Vesprini D; Garber JE; Lynch HT; Weber BL; Brown M Cancer Res; 2001 Jul; 61(14):5420-4. PubMed ID: 11454686 [TBL] [Abstract][Full Text] [Related]
7. [Generic screening for breast cancer]. Ponti A; Giordano L Epidemiol Prev; 1999; 23(4):369-71. PubMed ID: 10730478 [TBL] [Abstract][Full Text] [Related]
8. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations]. Ost E; Illiger HJ Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002 [No Abstract] [Full Text] [Related]
9. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Fackenthal JD; Olopade OI Nat Rev Cancer; 2007 Dec; 7(12):937-48. PubMed ID: 18034184 [TBL] [Abstract][Full Text] [Related]
10. Specific H-Ras minisatellite alleles in breast cancer susceptibility. Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon YJ; Bernard-Gallon D Anticancer Res; 1999; 19(6B):5191-6. PubMed ID: 10697533 [TBL] [Abstract][Full Text] [Related]
11. Hereditary breast cancer: high risk genes, genetic testing and clinical implications. Hamann U Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530 [TBL] [Abstract][Full Text] [Related]
12. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France. Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246 [TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252 [TBL] [Abstract][Full Text] [Related]
15. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
16. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254 [TBL] [Abstract][Full Text] [Related]
17. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers. Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154 [TBL] [Abstract][Full Text] [Related]
18. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Greenblatt MS; Chappuis PO; Bond JP; Hamel N; Foulkes WD Cancer Res; 2001 May; 61(10):4092-7. PubMed ID: 11358831 [TBL] [Abstract][Full Text] [Related]
19. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families. Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550 [TBL] [Abstract][Full Text] [Related]
20. [Genetic predisposition to breast cancer: a review in April 1998]. Stoppa-Lyonnet D Contracept Fertil Sex; 1999; 27(7-8):517-20. PubMed ID: 10495568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]